A Gene Panel Associated With Abemaciclib Utility in ESR1-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression is a research paper published in JCO Precision Oncology (2023). On theSindex it has a DataRank of 0.425. It has been cited 16 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.425
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: P50 CA168504
NCI NIH HHS
Grant: K12 CA087723
NCI NIH HHS
Grant: R01 CA129933
Howard Hughes Medical Institute
Fields of Study
MeSH Terms
Additional file 1 of Characterizing excision repair cross-complementing family genes as drug resistance biomarkers in breast cancer
Additional file 1 of Characterizing excision repair cross-complementing family genes as drug resistance biomarkers in breast cancer